Active ingredients: Clindamycin
Dalacin T Topical Solution.
Clear colourless aqueous solution.
One ml of Dalacin T Topical Solution contains the equivalent of 10 mg Clindamycin.
Excipients with known effect: Propylene glycol 50 mg/ml.
For the full list of excipients, see section 6.1.
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.
Hydrochloric acid (10%)
Sodium hydroxide (10%)
Bottle: White high density polyethylene bottle containing 30 ml, 50 ml or 60 ml.
Cap: Prolypropylene, linerless screw caps or Polypropylene screw caps lined with laminated films consisting of polyethylene, polyvinylidene chloride (PVdc) and polyethylene.
Applicator: Low-density polyethylene applicator made by Dab-O-Matic.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich Kent, CT13 9NJ, United Kingdom
Date of first authorisation: 18th January 1988
Date of latest renewal of authorisation: 7th August 2009